Related Experiment Video
Updated: Sep 28, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Ligand-based approaches to activity prediction for the early stage of structure-activity-relationship progression
Itsuki Maeda1, Akinori Sato1, Shunsuke Tamura1
1Graduate School of Science and Technology, Nara Institute of Science and Technology, 8916-5 Takayama-cho, Ikoma, Nara, 630-0192, Japan.
Abstract:
The retrospective evaluation of virtual screening approaches and activity prediction models are important for methodological development. However, for fair comparison, evaluation data sets must be carefully prepared. In this research, we compiled structure-activity-relationship matrix-based data sets for 15 biological targets along with many diverse inactive compounds, assuming the early stage of structure-activity-relationship progression. To use a large number of diverse inactive compounds and a limited number of active compounds, similarity profiles (SPs) are proposed as a set of molecular descriptors. Using these highly imbalanced data sets, we evaluated various approaches including SPs, under-sampling, support vector machine (SVM), and message passing neural networks. We found that for the under-sampling approaches, cluster-based sampling is better than random sampling. For virtual screening, SPs with inactive reference compounds and the under-sampling SVM also perform well. For classification, SPs with many inactive references performed as well as the under-sampling SVM trained on a balanced data set. Although the performance of SPs and the under-sampling SVM were comparable, SPs with many inactive references were preferable for selecting structurally distinct compounds from the active training compounds.
Related Concept Videos
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Drug Discovery: Overview
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Ligand Binding and Linkage

